The obesity-driven tumor progression has been linked to regulation of systemic risk factors like insulin and low-grade inflammation11, thus we evaluated the levels of these systemic factors in mice randomized to no wheel running or 6 weeks of wheel running. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.